JB

Jayashree Bommakanti

Active Director Director DIN 09331462
DIN 09331462 First appointment Oct 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2021
Shareholding value •••• Premium profile

About Jayashree Bommakanti

Data last updated:

Jayashree Bommakanti is a Director at Virtus Pharmaceuticals Private Limited (since 2021). The company operates in Chemicals. Virtus Pharmaceuticals Private Limited reported revenue of ₹1.02 Cr (FY 2023).

DIN 09331462
Primary Designation Director
Industry Chemicals
First Appointment 01 Oct 2021
Oldest Company Age 12 yrs
Largest company Virtus Pharmaceuticals Private Limited · ₹1.02 Cr (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Oct 20212014₹1.02 Cr (FY 2023)Active

Board colleagues of Jayashree Bommakanti

NameDINCompanyDesignation
Shyam Kumar Bommakanti06762121Virtus Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Virtus Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Jayashree Bommakanti

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jayashree Bommakanti

Jayashree Bommakanti currently holds 1 directorship: Virtus Pharmaceuticals Private Limited (Director, since 01 Oct 2021, revenue ₹1.02 Cr (FY 2023)).

Jayashree Bommakanti was first appointed on 01 Oct 2021 as Director at Virtus Pharmaceuticals Private Limited.

The current boards of Jayashree Bommakanti's companies include Shyam Kumar Bommakanti (Virtus Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available